In addition, we have shown the participation of ACSL4 in tumor resistance to hormone therapy2 and chemotherapy through the action of ABC transporters, with its downregulation or inhibition in TNBC cells contributing to effective therapeutic approaches10. This evidence concerns the gene ACSL4 and neoplasm.